(Q41451193)

English

The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-helicobacter pylori activity in vitro and in vivo.

scientific article published on 2 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-helicobacter pylori activity in vitro and in vivo (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Helicobacter pylori

1 reference

based on heuristic

inferred from title

antimicrobial peptide

1 reference

based on heuristic

inferred from title

author name string

Xiao-Lin Zhang

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

An-Min Jiang

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Zhong-You Ma

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Xian-Bao Li

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

You-Yi Xiong

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jin-Feng Dou

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jian-Fei Wang

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

2 March 2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3972-3985

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

copyright license

Creative Commons Attribution 4.0 International

2 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

How long will it take to reduce gastric cancer incidence by eradicating Helicobacter pylori infection?

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

The co-evolution of host cationic antimicrobial peptides and microbial resistance

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Antimicrobial peptides: primeval molecules or future drugs?

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Cationic host defense (antimicrobial) peptides

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

The roles of antimicrobial peptides in innate host defense

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Host defense peptides in wound healing.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Improved antimicrobial peptides based on acyl-lysine oligomers.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Pexiganan acetate.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

MSI-78, an Analogue of the Magainin Antimicrobial Peptides, Disrupts Lipid Bilayer Structure via Positive Curvature Strain

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

A high-resolution solid-state NMR approach for the structural studies of bicelles

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Local gastric and serum amoxicillin concentrations after different oral application forms

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20033972

21 January 2018

In vitro antibacterial properties of pexiganan, an analog of magainin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of Helicobacter pylori therapies in a clinical practice setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cationic antimicrobial peptides : issues for potential clinical use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori--the latest in diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/25738539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/MOLECULES20033972

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738539%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41451193&oldid=2121105278"